Development of a New Method for Liver Stiffness Measurement Using FibroScan
ConditionLiver Diseases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEchosens
About this trial
This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 114 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.
Eligibility criteria
Qualifiers
Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.
Adult patient able to give his written consent
Patient affiliated to the French Social Security system
Disqualifiers
Vulnerable patients
Patients with liver ascites
Patients with heart failure
Trial design
Treatments tested in this trial
- Research FibroScan (FS)
Treatment groups
114 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov